MARCH 2011 - Following Japan’s 8.9 magnitude earthquake and ensuing tsunami, DTRA supported Operation Tomodachi providing 24/7 consequence management and reachback support ensuring the safe containment of nuclear materials and preventing a nuclear meltdown. In September, DTRA’s International Counterproliferation Program expanded to include engagements in a total of 88 countries in Europe, Asia, and Africa.
AUGUST 2014 - DTRA led eﬀorts to eliminate 600 metric tons of declared Syrian CW at sea using specialized equipment and the Field Deployable Hydrolysis System.
FEBRUARY 2015 - During the Ebola outbreak in West Africa, DTRA provided transportable diagnostic labs, personal protective equipment, valuable vaccine and therapeutic test results leading to the FDA-approved treatment drug Zmapp.
JUNE 2018 - DTRA collaborated with the Government of Jordan to prevent, deter, detect and interdict illicit traﬃcking of WMD and related materials and has increased Jordanian frontier border force capabilities.
AUGUST 2018 - DTRA team members were awarded the Secretary of Defense Medal for Valor. The team willingly put themselves at risk, exposed themselves to lethal threats, direct enemy ﬁre and other explosives with one expert single-handedly fending oﬀ an insurgent onslaught.
Capping off nearly 20 years of DTRA efforts to counter the deadly Ebola virus, the FDA approves Merck's Ebola vaccine Ervebo. The start of this effort began in 2001, when DTRA and BioProtection Systems first partnered with Canada on tackling the deadly disease.
With the rapid worldwide spread of the SARS-CoV-2 virus and its disease COVID-19, DTRA's specialized capabilities were put to the test in many ways. The agency fulfilled the first of more than 40 equipment and training requests from 18 partner nations overwhelmed by the pandemic and is tapped to lead the critical mission of bringing the first shipment of diagnostic kits made in Italy to the United States.
DTRA's special role as the DoD’s dual-hatted Defense Agency and Combat Support Agency focused on countering WMD and Emerging Threats continues to grow. The agency continues to address WMD and CBRN threats it started dealing with years before the agency was established in 1998, and it's unique and specialized CWMD workforce continues to adapt to new and emerging threats and adversaries that are increasing and expanding their WMD, and to identify, anticipate and prepare solutions for the next threat to come our way.